High Level of Circulating Human Tissue Kallikrein Induces Hypotension in a Transgenic Mouse Model

References

• Margolius H. S. Tissue kallikreins and kinins: regulation and roles in hypertensive and diabetic diseases Annu. Rev. Pharmacol. Toxicol. 1989; 29: 343–364
   PubMed Web of Science ®Google Scholar
• Muller-Esterl W, Kininogens, Kinins, Kinships. Thromb. Haemost. 1989; 61: 2–6
   Google Scholar
• Bhoola D. K, Figueroa C. D, Worthy K. Bioregulation of kinins: kininogens, and kininases Pharmacol. Rev. 1992; 44: 1–80
   Google Scholar
• Elliot R., Nuzum F. R. Urinary excretion of a depressor substance (kallikrein of Frey and Kraut) in arterial hypertension. Endocrinology 1934; 18: 462–474
   Google Scholar
• Carretero O. A, Scicli A. G. The renal kallikrein-kinin system in human and experimental essential hypertension Clin. Wochenschr. 1971; 56: 113–125
   Google Scholar
• Margolius H. S, Geller R. G, Pisano J. J, Sjoerdsma A. Altered urinary kallikrein excretion in human hypertension. Lancet 1971; 2: 1063–1065
   PubMed Web of Science ®Google Scholar
• Margolius H. S, Horwitz D., Pisano J. J, Keiser H. R. Urinary kallikrein in hypertension: relationship to sodium intake and sodium-retaining steroid Circ. Res. 1974; 35: 820–825
   Google Scholar
• Carretero O. A, Polomski C., Hampton A., Scicli A. G. Urinary kallikrein, plasma renin and aldosterone in New Zealand genetically hypertensive (GH) rats Clin. Exp. Pharmacol. Physiol. 1976; 3: 55–59
   Google Scholar
• Carretero O. A, Amin V. M, Ocholik T., Scicli A. G, Koch J. Urinary kallikrein in rats bred for their susceptibility and resistance to the hypertensive effect of salt Circ. Res. 1978; 42: 727–731
   Google Scholar
• Ader J. L, Tran-Van T, Praddaude F. Low urinary excretion of active and total kallikrein in young spontaneously hypertensive rats and effect of long-term angiotensin converting enzyme inhibition J. Hypertens. 1986; 4: 151–153
   Google Scholar
• Ader J. L, Tran-Van T., Praddaude F. Renal tissue kallikrein in newborn and young SHR Am. J. Hypertens. 1987; 1: 53S–55S
   Web of Science ®Google Scholar
• Berry T. D, Hasstedt S. J, Hunt S. C, Wu L. L, Smith J. B, Ash O., Kuida H., Williams R. R. A gene for high urinary kallikrein may protect against hypertension in Utah kindreds. Hypertension 1989; 13: 3–8
   PubMed Web of Science ®Google Scholar
• Woodley-Miller C. M, Chao J., Chao L. Restriction fragment length polymorphisms mapped in spontaneously hypertensive rats using kallikrein probes. J. Hypertens. 1989; 7: 865–871
   PubMed Web of Science ®Google Scholar
• Pravenec M., Ken V., Kunes J., Scicli A. G, Carretero O. A, Simonet L., Kurtz T. W. Cosegregation of blood pressure with a kallikrein gene family polymorphism. Hypertension 1991; 17: 242–246
   PubMed Web of Science ®Google Scholar
• Wang J., Xiong W., Yang Z., Davis T., Dewey M. J, Chao J., Chao L. Human tissue kallikrein induces hypotension in transgenic mice. Hypertension 1994; 23: 236–43
   PubMed Web of Science ®Google Scholar
• Pinkert C. A, Ornitz D. M, Brinster R. L, Palmiter R D. An albumin enhancer located 10 kb upstream functions along with its promoter to direct efficient, liver-specific expression in transgenic mice. Genes Dev. 1987; 1: 268–76
   PubMed Web of Science ®Google Scholar
• Bieberich C. J, Utset M. F, Awgulewitsch A., Ruddle F. H. Evidence for positive and negative regulation of the Hox-3.1 gene Proc. Natl. Acad. Sci. USA 1990; 87: 8462–6
   PubMed Web of Science ®Google Scholar
• Sambrook J., Fritsch E. F, Maniatis T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, NY 1989; 7.19–7.22, Cold Spring Harbor
   Google Scholar
• Wang C., Chao L., Chao J. Direct gene delivery of human tissue kallikrein reduces blood pressure in spontaneously hypertensive rats J. Clin. Invest. 1995; 95: 1710–6
   Google Scholar
• Lowry O. H, Rosebrough N. J, Farr A. L, Randall R. J. Protein measurement with the folin phenol reagent J. Biol. Chem. 1951; 193: 265–275
   Web of Science ®Google Scholar
• Herbst R. S, Friedman N., Darnell J. E, Jr, Babiss L E. Positive and negative regulatory elements in the mouse albumin enhancer Proc. Natl. Acad. Sci. USA 1989; 86: 1553–7
   PubMed Web of Science ®Google Scholar
• Shimamoto K., Mayfield R. K, Margolius H. S, Chao J., Stroud W., Kaplan A. P. Immunoreactive tissue kallikrein in human serum J. Lab. Clin. Med. 1984; 103: 731–738
   PubMedGoogle Scholar
• Powell D. J, Friedman J. M, Oulette A. J, Krauter K. S, Darnell J. E, Jr. Transcriptional and post-transcriptional control of specific messenger RNAs in adult and embryonic liver J. Mol. Biol. 1984; 179: 21–35
   Web of Science ®Google Scholar
• Liu J. K, Bergman Y., Zaret K. S. The mouse albumin promoter and a distal upstream site are simultaneously DNase I hypersensitive in liver chromatin and bind similar liver-abundant factors in vitro. Genes Dev. 1988; 2: 528–41
   PubMed Web of Science ®Google Scholar
• Geiger R., Fink E., Lottspeich F., Henschen A., Fritz H. Human urinary kallikrein-biochemistry and physiological studies Fresenius Z. Anal. Chem. 1980; 301: 172–173
   Google Scholar
• Chen Z., Bode. W Refined 2.5 AR X-ray crystal structure of the complex formed by porcine kallikrein A and the bovine pancreatic trypsin inhibitor. Crystallization, Patterson search, structure determination, refinement, structure and comparison with its components and with the bovine trypsin-pancreatic trypsin inhibitor complex. J. Mol. Biol. 1983; 164: 283–311
   Google Scholar
• Hock F. J, Wirth K., Albus U., Linz W., Gerhards H. J, Wiemer G., Henke S., Breipohl G., Konig W., Knolle J., Scholkens B. A. Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies Br. J. Pharmacol. 1991; 102: 769–73
   Google Scholar
• Chao J., Chao L. Biochemistry, regulation and potential function of kallistatin Biol. Chem. Hoppe-Seyler 1995; 376(12)705–713
   PubMed Web of Science ®Google Scholar
• Figueroa C. D, MacIver A. G, Bhoola K. D. Identification of a tissue kallikrein in human polymorphonuclear leucocytes Br. J. Haematol. 1989; 72: 321–8
   Google Scholar
• Roblero J., Croxatto H., Garcia R., Corthorn J., de Vito E. Kallikrein like activity in perfusates and urine of isolated rat kidneys Am. J. Physiol. 1976; 231: 1383–9
   Web of Science ®Google Scholar
• Chen L. M, Song Q., Chao L., Chao J. Cellular localization of tissue kallikrein and kallistatin mRNAs in human kidney. Kidney Int. 1995; 48: 690–697
   PubMed Web of Science ®Google Scholar
• Figueroa C. D, Gonzalez C. B, Grigoriev S., Alla S. A, Haasemann M., Jarnagin K., Muller-Esterl W. Probing for the bradykinin B2receptor in rat kidney by anti-peptide and anti-ligand antibodies J. Histochem. Cytochem. 1995; 43(2)137–148
   PubMed Web of Science ®Google Scholar
• Song Q., Wang D. Z, Harley R. A, Chao L., Chao J. Cellular localization of low molecular weight kininogen and bradykinin B2receptor mRNAs in human kidney. Am. J. physiol. 1996, in press.
   Web of Science ®Google Scholar
• Anderson W. F. Gene therapy. Sci. Am. 1995; 273(3)124
   PubMed Web of Science ®Google Scholar